The Comprehensive Addiction and Recovery Justice Grant Reauthorization Act (S 2540) extends federal funding for state and local programs that provide addiction treatment and recovery services to individuals involved in the justice system, such as those in courts or correctional facilities. It updates the authorization period from 2019-2023 to 2026-2030, ensuring continued support through 2030 without altering annual funding amounts. This reauthorization directly affects state and local agencies administering these grants, which help connect people with substance use disorders to treatment while navigating legal processes. The bill does not specify new funding levels but secures program continuity by extending the timeframe for grant distribution.
This bill requires hospitals to bill Medicare and other insurers using separate unique identifiers for off-campus outpatient departments (starting January 1, 2026), rather than treating them as part of the main hospital. It removes exceptions that allowed hospitals to bill higher rates for services at off-campus locations, mandating that these departments use specific billing forms (HIPAA X12 837P or CMS 1500) with their own identifiers. The bill directly affects hospitals operating off-campus departments, Medicare, and health insurance issuers, ensuring claims for these locations are processed accurately. It also directs the National Association of Insurance Commissioners to develop model regulations helping insurers reject improper claims. The key change is standardizing billing to prevent overcharging for off-campus services.
This bill removes age restrictions preventing working adults with disabilities from accessing Medicaid buy-in programs. It modifies the Social Security Act to eliminate the "less than 65" requirement, allowing individuals aged 16 and older who earn above Supplemental Security Income (SSI) limits but would otherwise qualify for SSI to enroll in Medicaid buy-in programs. The key change ensures states can provide Medicaid coverage to this group without age barriers, directly affecting working adults with disabilities who previously faced eligibility cutoffs at age 65. The bill also provides a transition period for states already offering similar programs, requiring no changes before January 1, 2028.
Sub-Topics
Medicaid
Tags
People with Disabilities
S 3421 requires medical device manufacturers and importers to use a standardized electronic system for recall notifications. This system must include specific mandatory information like device identifiers, risk details, and patient safety instructions, and must be shared with health professionals and patients for high-risk recalls (e.g., implanted, life-sustaining, or pediatric devices). The bill mandates that manufacturers submit these notifications electronically to the FDA within 180 days of the system's launch, with the FDA reviewing them within 2 business days. It also creates a public, searchable database of all recall information. The law directly affects device manufacturers, healthcare facilities, and patients receiving affected devices.
This bill directs the Health Resources and Services Administration (HRSA) to create a real-time online dashboard tracking graduate medical education residency programs. It requires the dashboard to show residency application numbers, geographic applicant distribution, match rates, training completion, and physician placement in rural/underserved areas - all using de-identified data to protect privacy. The dashboard will be developed with collaboration from agencies like Medicare (CMS) and the VA, and must integrate with existing systems to avoid duplication. HRSA must report annually to Congress on the dashboard's operation and findings related to physician workforce distribution.
The Kidney Care Access Protection Act (S 2730) improves access to innovative treatments for patients with end-stage renal disease (ESRD) who require dialysis. The bill extends Medicare's Transitional Drug Add-On Payment Adjustment (TDAPA) period for new renal dialysis drugs approved after 2020 and creates a permanent post-TDAPA payment adjustment starting in 2026. It clarifies that Medicare payments will cover only drugs specifically for kidney disease treatment, not for related conditions like diabetes or heart disease. The legislation also requires Medicare Advantage plans to cover innovative kidney care therapies and adjusts payment calculations to better reflect actual costs for providers. These changes will take effect on January 1, 2026, for treatments provided after that date.
Due Process Continuity of Care Act This bill allows an otherwise eligible individual who is in custody pending disposition of charges (i.e., pretrial detainees) to receive Medicaid benefits at the option of the state. The bill also provides for state planning grants to support the provision of such benefits.
HR 5384, the MORE Act, changes rules for health profession opportunity grants under the Social Security Act. It requires the Secretary to give preference to grant applicants who partner with specific entities: state/local government/social service providers, colleges/apprenticeship programs, and healthcare employers/unions. This directly affects applicants seeking federal grants to support health workforce training programs. The policy change takes effect on October 1, 2025. The bill modifies selection criteria without altering grant funding levels or creating new programs.
HR 1191, the Supporting Access to Rural Community Hospitals Act of 2025, waives certain distance requirements under Medicare law for specific rural hospitals. It allows hospitals participating in a Medicare demonstration program as of the bill's enactment date to be designated as critical access hospitals during a one-year window after the law takes effect. This change directly affects rural community hospitals enrolled in the Medicare demonstration program, making it easier for them to qualify for critical access hospital status. The key mechanism adds a new pathway to designation under existing Medicare rules, specifically for hospitals already in the demonstration program.
S 2131, the Dads Matter Act of 2025, requires the Health and Human Services Secretary to launch a public awareness campaign within two years and issue state guidance within one year to improve father involvement in prenatal and postpartum care. The campaign will promote father engagement through public messaging, while the guidance will direct states to train healthcare providers (like OB-GYNs and hospitals) on supporting fathers’ roles during pregnancy and early childcare. Key provisions focus on increasing prenatal care attendance, reducing maternal health risks, improving breastfeeding success, and promoting father-infant bonding. This policy directly affects healthcare systems nationwide by changing provider practices to better include fathers in maternal and infant health support.
